09.07.2019 Views

Diagnostic Ultrasound - Abdomen and Pelvis

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Peritoneal Carcinomatosis<br />

Diagnoses: Abdominal Wall/Peritoneal Cavity<br />

• Similar to carcinomatosis: Thick nodular masses involving<br />

anterior parietal peritoneum, becoming confluent <strong>and</strong><br />

cake-like<br />

• Large solid omental <strong>and</strong> mesenteric masses often<br />

infiltrating bowel <strong>and</strong> mesentery<br />

• Smaller volume of ascites<br />

• Look for associated pleural calcification (sign of asbestos<br />

exposure)<br />

Peritoneal Tuberculosis<br />

• Ileocecal mural thickening, matted, hypoperistaltic small<br />

bowel loops, necrotic lymph nodes, splenomegaly, or<br />

splenic calcifications favor tuberculosis<br />

• Wet type (90%): Ascites with increased density ±<br />

mesenteric nodes<br />

• Fixed fibrotic type (7%): Smooth thickening of peritoneum,<br />

nodular mesenteric masses, loculated ascites ± calcification<br />

• Dry type (3%): Peritoneal fibrosis<br />

Peritoneal Sarcomatosis<br />

• Peritoneal spread of sarcoma most commonly from<br />

gastrointestinal stromal tumors, liposarcoma, <strong>and</strong><br />

leiomyosarcoma<br />

• Discrete well-defined masses with more smooth outlines,<br />

typically > 2 cm<br />

• Less ascites, peritoneal thickening, omental cake, serosal<br />

implants, <strong>and</strong> lymphadenopathy than carcinomatosis<br />

Peritoneal Lymphomatosis<br />

• Rare peritoneal spread of lymphoma, typically aggressive<br />

non-Hodgkin (diffuse large B cell most common)<br />

• Bulky omental thickening or smooth peritoneal nodules<br />

(typically > 5 cm), less ascites<br />

• Lymphadenopathy, mesenteric masses ("s<strong>and</strong>wiching"<br />

vessels), <strong>and</strong> splenomegaly help distinguish from<br />

carcinomatosis <strong>and</strong> sarcomatosis<br />

• Intense FDG uptake, nodular or diffuse<br />

PATHOLOGY<br />

General Features<br />

• Etiology<br />

○ Metastatic disease to peritoneal surfaces, omentum, <strong>and</strong><br />

mesentery<br />

○ Most commonly from ovarian, colorectal, gastric, breast<br />

<strong>and</strong> pancreatic cancer<br />

– Less common: Lung <strong>and</strong> renal carcinoma<br />

○ Sarcomas <strong>and</strong> lymphomas may also spread<br />

intraperitoneally<br />

• Genetics<br />

○ Colorectal, endometrial, <strong>and</strong> ovarian cancers related to<br />

Lynch syndrome<br />

Staging, Grading, & Classification<br />

• Peritoneal metastases indicate stage IV disease (excluding<br />

ovarian carcinoma)<br />

Gross Pathologic & Surgical Features<br />

• Infiltrating masses of peritoneal surfaces, omentum, <strong>and</strong><br />

mesentery<br />

• Omental cake: Replacement of omental fat by tumor <strong>and</strong><br />

fibrosis<br />

• Ascites: Clear or turbid <strong>and</strong> thick (viscous/gelatinous)<br />

Microscopic Features<br />

• Varies according to primary tumor<br />

○ Most commonly adenocarcinoma<br />

CLINICAL ISSUES<br />

Presentation<br />

• Most common signs/symptoms<br />

○ Abdominal distension <strong>and</strong> pain, weight loss, malaise,<br />

fever<br />

• Other signs/symptoms<br />

○ Progression of known malignancy<br />

• Clinical profile<br />

○ New presentation: Diagnosis may be made by<br />

paracentesis or tissue sampling of mass<br />

○ May have elevated tumor markers such as CA125 or CEA<br />

Demographics<br />

• Age<br />

○ Adults generally > 40 years<br />

○ Younger patients with hereditary syndromes<br />

• Gender<br />

○ More common in females than males, due to ovarian<br />

carcinoma<br />

Natural History & Prognosis<br />

• Variable, depending on primary tumor; poor prognosis in<br />

general<br />

• Progressive if untreated<br />

• Complication: Bowel obstruction<br />

Treatment<br />

• Depends on pathology<br />

• Cytoreductive surgery ± hyperthermic intraperitoneal<br />

chemotherapy<br />

• Combination of systemic <strong>and</strong> intraperitoneal<br />

chemotherapy<br />

DIAGNOSTIC CHECKLIST<br />

Consider<br />

• Peritoneal sarcomatosis if there are large, well-defined<br />

smooth, intraperitoneal masses with no omental<br />

involvement <strong>and</strong> minimal ascites<br />

• Peritoneal lymphomatosis if there are also large mesenteric<br />

<strong>and</strong> retroperitoneal nodal masses <strong>and</strong> splenomegaly<br />

• TB peritonitis if there is ileocecal involvement, necrotic, or<br />

calcified lymph nodes<br />

SELECTED REFERENCES<br />

1. Wasnik AP et al: Primary <strong>and</strong> secondary disease of the peritoneum <strong>and</strong><br />

mesentery: review of anatomy <strong>and</strong> imaging features. Abdom Imaging.<br />

40(3):626-42, 2015<br />

2. Diop AD et al: CT imaging of peritoneal carcinomatosis <strong>and</strong> its mimics. Diagn<br />

Interv Imaging. ePub, 2014<br />

3. O'Neill AC et al: Differences in CT features of peritoneal carcinomatosis,<br />

sarcomatosis, <strong>and</strong> lymphomatosis: retrospective analysis of 122 cases at a<br />

tertiary cancer institution. Clin Radiol. 69(12):1219-27, 2014<br />

4. Vicens RA et al: Multimodality imaging of common <strong>and</strong> uncommon<br />

peritoneal diseases: a review for radiologists. Abdom Imaging. ePub, 2014<br />

5. Cabral FC et al: Peritoneal lymphomatosis: CT <strong>and</strong> PET/CT findings <strong>and</strong> how<br />

to differentiate between carcinomatosis <strong>and</strong> sarcomatosis. Cancer Imaging.<br />

13:162-70, 2013<br />

6. Oei TN et al: Peritoneal sarcomatosis versus peritoneal carcinomatosis:<br />

imaging findings at MDCT. AJR Am J Roentgenol. 195(3):W229-35, 2010<br />

630

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!